01/23/2025
2:38 PM | Bioxytran (Filer)
| Form DEL AM | |
01/22/2025
4:20 PM | Bioxytran (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
01/22/2025
5:05 AM | Bioxytran (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2025
9:05 AM | Bioxytran (Issuer)
Hoberman Alan M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
9:08 AM | Bioxytran (Issuer)
CONAWAY DALE H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
9:10 AM | Bioxytran (Issuer)
MILANOVA RADKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
9:03 AM | Bioxytran (Issuer)
Utter Anders (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
10:44 AM | Bioxytran (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
10:39 AM | Bioxytran (Filer)
| Form 10-K/A | |
01/10/2025
10:31 AM | Bioxytran (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
8:40 PM | Bioxytran (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
10/28/2024
4:59 PM | Bioxytran (Issuer)
Utter Anders (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
5:06 PM | Bioxytran (Issuer)
PLATT DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
5:09 PM | Bioxytran (Issuer)
MILANOVA RADKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
4:21 PM | Bioxytran (Issuer)
Hoberman Alan M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
4:29 PM | Bioxytran (Issuer)
Soderquist Ola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
4:32 PM | Bioxytran (Issuer)
CONAWAY DALE H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
4:35 PM | Bioxytran (Issuer)
Sheikh Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
4:59 PM | Bioxytran (Issuer)
Sheikh Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
5:02 PM | Bioxytran (Issuer)
Soderquist Ola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
4:30 PM | Bioxytran (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
4:26 PM | Bioxytran (Issuer)
MILANOVA RADKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
4:10 PM | Bioxytran (Issuer)
PLATT DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:39 PM | Bioxytran (Issuer)
Hoberman Alan M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:46 PM | Bioxytran (Issuer)
CONAWAY DALE H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:52 PM | Bioxytran (Issuer)
Utter Anders (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
5:02 AM | Bioxytran (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
5:03 AM | Bioxytran (Filer)
| Form RW | |
07/03/2024
7:06 PM | Bioxytran (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:43 PM | Bioxytran (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
2:39 PM | Bioxytran (Filer)
| Form 10-Q/A | |
04/19/2024
3:50 PM | Bioxytran (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/19/2024
3:25 PM | Bioxytran (Issuer)
MILANOVA RADKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
3:26 PM | Bioxytran (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
3:21 PM | Bioxytran (Issuer)
Hoberman Alan M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
3:23 PM | Bioxytran (Issuer)
CONAWAY DALE H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
1:46 PM | Bioxytran (Issuer)
MILANOVA RADKA (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:56 PM | Bioxytran (Issuer)
CONAWAY DALE H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:58 PM | Bioxytran (Issuer)
Utter Anders (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:48 PM | Bioxytran (Issuer)
Hoberman Alan M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | Bioxytran (Issuer)
PLATT DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Do this Before Elon’s Reveal on April 23rd (Ad) Elon’s newest tech could pay you an extra $30,000 a year — while you sleep.
It’s smaller than a quarter but designed to power a $9 trillion AI revolution.
And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. |
03/22/2024
4:17 PM | Bioxytran (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
Free BIXT Stock Alerts